8,725 Shares in HealthEquity, Inc. (NASDAQ:HQY) Purchased by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC purchased a new position in HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 8,725 shares of the company’s stock, valued at approximately $837,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Paladin Wealth LLC purchased a new position in shares of HealthEquity during the 3rd quarter worth about $39,000. UMB Bank n.a. increased its position in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in HealthEquity during the second quarter worth approximately $73,000. GAMMA Investing LLC boosted its holdings in shares of HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after purchasing an additional 344 shares during the last quarter. Finally, Quarry LP grew its stake in shares of HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after buying an additional 1,089 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In related news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares of the company’s stock, valued at $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,289 shares of company stock worth $3,355,718 in the last 90 days. 2.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. BTIG Research increased their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Bank of America raised their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Finally, The Goldman Sachs Group initiated coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Price Performance

HQY opened at $104.74 on Wednesday. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $105.82. The firm has a market cap of $9.08 billion, a price-to-earnings ratio of 96.09, a PEG ratio of 1.80 and a beta of 0.54. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a fifty day simple moving average of $99.04 and a 200 day simple moving average of $86.92.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the previous year, the firm earned $0.40 earnings per share. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.